Unravelling the allosteric binding mode of αD-VxXXB at nicotinic acetylcholine receptors

Front Pharmacol. 2023 Apr 13:14:1170514. doi: 10.3389/fphar.2023.1170514. eCollection 2023.

Abstract

αD-conotoxins are 11 kDa homodimers that potently inhibit nicotinic acetylcholine receptors (nAChRs) through a non-competitive (allosteric) mechanism. In this study, we describe the allosteric binding mode of the granulin-like C-terminal (CTD) of VxXXB bound to Lymnea stagnalis acetylcholine binding protein (Ls-AChBP), a soluble homologue of the extracellular ligand-binding domain of nAChRs. This co-crystal complex revealed a novel allosteric binding site for nAChR antagonists outside the C-loop that caps the orthosteric site defined by the nAChR agonist nicotine and the antagonist epibatidine. Mutational and docking studies on Ls-AChBP supported a two-site binding mode for full-length VxXXB, with the first CTD binding site located outside the C-loop as seen in the co-crystal complex, with a second CTD binding site located near the N-terminal end of the adjacent subunit of AChBP. These results provide new structural insight into a novel allosteric mechanism of nAChR inhibition and define the cooperative binding mode of the N-terminal domain linked granulin core domains of αD-conotoxins.

Keywords: AChBP; allosteric; granulin fold; pharmacology; α-conotoxin; α7 nAChR.

Grants and funding

A National Health and Medical Research Council of Australia Fellowship (APP1119056) and Program Grant (APP1072113), and an Australian Research Council Discovery Grant (DP200103087) provided research funding and support to RL. TH was supported by a University of Queensland International scholarship (UQI).